American Renal Associates Holdings Inc (ARA.N)
ARA.N on New York Stock Exchange
16.42USD
19 Apr 2018
16.42USD
19 Apr 2018
Change (% chg)
$-0.31 (-1.85%)
$-0.31 (-1.85%)
Prev Close
$16.73
$16.73
Open
$16.72
$16.72
Day's High
$16.72
$16.72
Day's Low
$16.12
$16.12
Volume
33,588
33,588
Avg. Vol
41,334
41,334
52-wk High
$24.02
$24.02
52-wk Low
$9.91
$9.91
Consensus Recommendations
Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
---|---|---|---|
Outperform | 0.19 | December | 20 Apr 2018 |
Analyst Recommendations and Revisions
1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
---|---|---|---|---|
(1) BUY | 1 | 1 | 2 | 2 |
(2) OUTPERFORM | 1 | 1 | 1 | 1 |
(3) HOLD | 1 | 1 | 0 | 0 |
(4) UNDERPERFORM | 0 | 0 | 0 | 0 |
(5) SELL | 0 | 0 | 0 | 0 |
No Opinion | 0 | 0 | 0 | 0 |
Mean Rating | 2.00 | 2.00 | 1.33 | 1.33 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
# of Estimates | Mean | High | Low | 1 Year Ago |
|
---|---|---|---|---|---|
SALES (in millions) | |||||
Quarter Ending Jun-18 | 2 | 199.50 | 201.00 | 198.00 | 210.70 |
Quarter Ending Sep-18 | 2 | 203.00 | 205.00 | 201.00 | 217.70 |
Year Ending Dec-18 | 2 | 802.00 | 808.00 | 796.00 | 860.56 |
Year Ending Dec-19 | 2 | 869.50 | 875.00 | 864.00 | 933.33 |
Earnings (per share) | |||||
Quarter Ending Jun-18 | 3 | 0.19 | 0.24 | 0.14 | 0.16 |
Quarter Ending Sep-18 | 3 | 0.22 | 0.24 | 0.20 | 0.19 |
Year Ending Dec-18 | 3 | 0.74 | 0.86 | 0.62 | 0.70 |
Year Ending Dec-19 | 3 | 0.84 | 0.95 | 0.66 | 0.86 |
LT Growth Rate (%) | 1 | 22.30 | 22.30 | 22.30 | 10.93 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
---|---|---|---|---|
SALES (in millions) | ||||
Quarter Ending Dec-17 | 195.32 | 194.38 | 0.94 | 0.48 |
Quarter Ending Sep-17 | 194.60 | 187.71 | 6.89 | 3.54 |
Quarter Ending Jun-17 | 187.63 | 185.99 | 1.64 | 0.87 |
Quarter Ending Mar-17 | 185.39 | 177.02 | 8.37 | 4.51 |
Quarter Ending Dec-16 | 197.98 | 199.11 | 1.13 | 0.57 |
Earnings (per share) | ||||
Quarter Ending Dec-17 | 0.15 | 0.18 | 0.03 | 17.42 |
Quarter Ending Sep-17 | 0.16 | 0.19 | 0.03 | 16.92 |
Quarter Ending Jun-17 | 0.12 | 0.16 | 0.04 | 29.03 |
Quarter Ending Mar-17 | 0.10 | 0.06 | 0.04 | 41.00 |
Quarter Ending Dec-16 | 0.28 | 0.26 | 0.02 | 6.04 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
---|---|---|---|---|---|
SALES (in millions) | |||||
Quarter Ending Jun-18 | 199.50 | 199.77 | 200.77 | 203.40 | 210.70 |
Quarter Ending Sep-18 | 203.00 | 202.43 | 203.56 | 207.82 | 217.70 |
Year Ending Dec-18 | 802.00 | 801.93 | 805.48 | 823.25 | 860.56 |
Year Ending Dec-19 | 869.50 | 870.57 | 872.72 | 900.00 | 933.33 |
Earnings (per share) | |||||
Quarter Ending Jun-18 | 0.19 | 0.20 | 0.20 | 0.19 | 0.16 |
Quarter Ending Sep-18 | 0.22 | 0.21 | 0.21 | 0.19 | 0.19 |
Year Ending Dec-18 | 0.74 | 0.73 | 0.74 | 0.73 | 0.70 |
Year Ending Dec-19 | 0.84 | 0.82 | 0.84 | 0.88 | 0.86 |
Estimates Revisions Summary
Last Week | Last 4 Weeks | |||
---|---|---|---|---|
Number Of Revisions: | Up | Down | Up | Down |
Revenue | ||||
Quarter Ending Jun-18 | 0 | 1 | 0 | 1 |
Quarter Ending Sep-18 | 1 | 0 | 1 | 0 |
Year Ending Dec-18 | 0 | 0 | 0 | 0 |
Year Ending Dec-19 | 0 | 0 | 0 | 0 |
Earnings | ||||
Quarter Ending Jun-18 | 0 | 1 | 0 | 1 |
Quarter Ending Sep-18 | 1 | 0 | 1 | 0 |
Year Ending Dec-18 | 0 | 0 | 0 | 0 |
Year Ending Dec-19 | 0 | 0 | 0 | 0 |
- BRIEF-United Healthcare Insurance Co And United Healthcare Services Files Complaint Against American Renal Associates
- BRIEF-American Renal Associates & Its Unit Are Defendants In Lawsuit
- BRIEF-American Renal Associates Holdings Qtrly EPS $0.05
- BRIEF-American Renal Associates Settles Shareholder Class Action Litigation
- BRIEF-American Renal Associates Holdings reports adj. EPS $0.19